Pfizer (PFE) Inventory (2009 - 2026)

Pfizer (PFE) has 18 years of Inventory data on file, last reported at $10.7 billion in Q1 2026.

• Inventory for Q1 2026 came in at $10.7 billion, down 1.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.7 billion (down 1.7% YoY), and the FY2025 annual result was $10.7 billion, down 1.82% from the prior year.
• Inventory steadied at $10.7 billion in Q1 2026 per PFE's latest filing, from $10.7 billion in the prior quarter.
• Over five years, Inventory peaked at $11.7 billion in Q3 2024 and troughed at $9.0 billion in Q4 2022.
• A 5-year average of $10.6 billion and a median of $10.7 billion in 2025 frame the typical range for Inventory.
• The sharpest annual moves came in 2022 and 2023: Inventory climbed 17.5% in 2022, then declined 4.39% in 2023.
• A 5-year view of Inventory shows it stood at $9.0 billion in 2022, then gained by 13.45% to $10.2 billion in 2023, then climbed by 6.5% to $10.9 billion in 2024, then retreated by 1.82% to $10.7 billion in 2025, then advanced by 0.12% to $10.7 billion in 2026.
• Business Quant data shows PFE's Inventory at $10.7 billion in Q1 2026, $10.7 billion in Q4 2025, and $11.5 billion in Q3 2025.